本页面由Tiger Trade Technology Pte. Ltd.提供服务

Enlivex Therapeutics Ltd.

0.1734
-0.0258-12.95%
盘后:0.18000.0066+3.81%19:58 EDT
成交量:65.90万
成交额:11.58万
市值:425.04万
市盈率:0.00
高:0.1831
开:0.1690
低:0.1690
收:0.1992
52周最高:27.15
52周最低:0.1690
股本:2,451.19万
流通股本:1,234.92万
量比:1.17
换手率:5.34%
股息:- -
股息率:- -
每股收益(TTM):279.32
每股收益(LYR):382.20
净资产收益率:162.86%
总资产收益率:-0.61%
市净率:0.00
市盈率(LYR):0.00

数据加载中...

2026/08/14

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/28

SEC问询函

Form CORRESP - Correspondence
2026/03/25

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2026/03/13

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/12/30

SEC问询函

Form CORRESP - Correspondence
2025/05/09

SEC问询函

Form CORRESP - Correspondence
2025/05/01

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/11/14

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/04/30

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/04/10

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/05/03

SEC问询函

CORRESP [Cover] - Correspondence
2022/04/29

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/06/04

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/04/30

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/10

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/02/09

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/08/14

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/05/18

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/30

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/04/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]